Clinical value of urinary retinol‑binding protein in ascites due to cirrhosis

Xia,Yujing; Li,Jingjing; Li,Sainan; Liu,Tong; Zhou,Yuqing; Yin,Qin; Wang,Jianrong; Lu,Wenxia; Zhang,Rong; Zheng,Yuanyuan; Wang,Fan; Lu,Jie; Chen,Kan; Dai,Weiqi; Zhou,Yingqun; Guo,Chuanyong

doi:10.3892/etm.2017.5190

Clinical value of urinary retinol‑binding protein in ascites due to cirrhosis

Authors:
- Yujing Xia
- Jingjing Li
- Sainan Li
- Tong Liu
- Yuqing Zhou
- Qin Yin
- Jianrong Wang
- Wenxia Lu
- Rong Zhang
- Yuanyuan Zheng
- Fan Wang
- Jie Lu
- Kan Chen
- Weiqi Dai
- Yingqun Zhou
- Chuanyong Guo
View Affiliations

Affiliations: Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China
Published online on: September 22, 2017 https://doi.org/10.3892/etm.2017.5190
Pages: 5228-5234

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the clinical value of urinary retinol‑binding protein (RBP) level in the prognosis of cirrhotic ascites by assessment of the RBP levels prior to and following ascites treatment. The levels of urinary RBP, urinary microalbumin (mAlb), serum urea nitrogen (urea) and serum creatinine (Cr), and the estimated glomerular filtration rate (eGFR) were measured in 90 patients with cirrhosis and ascites hospitalized in a single institution between May 2011 and January 2012, and in 30 healthy controls. The levels of urinary mAlb, serum urea and serum Cr were higher in the cirrhotic patients compared with the healthy controls (P<0.05). Urinary RBP levels were significantly higher and eGFR was significantly lower in the liver cirrhosis group compared with the healthy control group (P<0.01). Urinary RBP, urinary mAlb, serum urea and serum Cr increased and eGFR decreased as the severity of the ascites increased (P<0.05). Urinary RBP was significantly higher in patients whose ascites did not respond or was refractory compared with those in whom it subsided (P<0.05), exhibiting a gradual increase over time in the former and a gradual reduction over time in the latter group (P<0.05). Increased urinary RBP and decreased eGFR in the early stage of cirrhosis ascites suggested impaired renal function, which serves a role in the process of ascites formation. These results indicated that urinary RBP is a sensitive indicator of early renal injury in patients with ascites due to cirrhosis and is closely associated with the progression of cirrhotic ascites.

View Figures

View References

1	Sivanathan V, Kittner JM, Sprinzl MF, Weinmann A, Koch S, Wiltink J, Nguyen-Tat M, Marquardt JU, Wörns MA, Zimmermann T, et al: Etiology and complications of liver cirrhosis: Data from a German centre. Dtsch Med Wochenschr. 139:1758–1762. 2014.(In German). PubMed/NCBI
2	Silva MJ, Rosa MV, Nogueira PJ and Calinas F: Ten years of hospital admissions for liver cirrhosis in portugal. Eur J Gastroenterol Hepatol. 27:1320–1326. 2015. View Article : Google Scholar : PubMed/NCBI
3	Qua CS and Goh KL: Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country. J Gastroenterol Hepatol. 26:1333–1337. 2011. View Article : Google Scholar : PubMed/NCBI
4	Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ and Naghavi M: Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 12:1452014. View Article : Google Scholar : PubMed/NCBI
5	Sandhu BS and Sanyal AJ: Management of ascites in cirrhosis. Clin Liver Dis. 9:715–732, viii. 2005. View Article : Google Scholar : PubMed/NCBI
6	Runyon BA; AASLD Practice Guidelines Committee, : Management of adult patients with ascites due to cirrhosis: An update. Hepatology. 49:2087–2107. 2009. View Article : Google Scholar : PubMed/NCBI
7	Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I, et al: Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 4:1385–1394. 2006. View Article : Google Scholar : PubMed/NCBI
8	Salerno F, Cammà C, Enea M, Rössle M and Wong F: Transjugular intrahepatic portosystemic shunt for refractory ascites: A meta-analysis of individual patient data. Gastroenterology. 133:825–834. 2007. View Article : Google Scholar : PubMed/NCBI
9	Garcia-Tsao G: Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 120:726–748. 2001. View Article : Google Scholar : PubMed/NCBI
10	Sabri M, Saps M and Peters JM: Pathophysiology and management of pediatric ascites. Curr Gastroenterol Rep. 5:240–246. 2003. View Article : Google Scholar : PubMed/NCBI
11	Witte MH, Witte CL and Dumont AE: Progress in liver disease: Physiological factors involved in the causation of cirrhotic ascites. Gastroenterology. 61:742–750. 1971.PubMed/NCBI
12	Levick JR and Michel CC: Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 87:198–210. 2010. View Article : Google Scholar : PubMed/NCBI
13	Wongcharatrawee S and Garcia-Tsao G: Clinical management of ascites and its complications. Clin Liver Dis. 5:833–850. 2001. View Article : Google Scholar : PubMed/NCBI
14	Schrier RW: Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med. 319:1127–1134. 1988. View Article : Google Scholar : PubMed/NCBI
15	Levy M and Wexler MJ: Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis. Am J Physiol. 253:F664–F671. 1987.PubMed/NCBI
16	Kostreva DR, Castaner A and Kampine JP: Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol. 238:R390–R394. 1980.PubMed/NCBI
17	Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH and Rodés J: Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 8:1151–1157. 1988. View Article : Google Scholar : PubMed/NCBI
18	Donati G, Piscaglia F, Coli L, Silvagni E, Righini R, Donati G, Pini P, Stefoni S and Bolondi L: Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Aliment Pharmacol Ther. 26:717–726. 2007. View Article : Google Scholar : PubMed/NCBI
19	Catalina MV, Barrio J, Anaya F, Salcedo M, Rincón D, Clemente G and Bañares R: Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int. 23 Suppl 3:S39–S43. 2003. View Article : Google Scholar
20	Jiang SM, Zhou GW, Shen C, Yan JQ, Wan L, Li QY, Yang WP, Shen BY, Chen H, Peng CH and Li HW: A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension. Zhonghua Wai Ke Za Zhi. 46:1699–1702. 2008.(In Chinese). PubMed/NCBI
21	Helen MN and Newcomer ME: The structure of human retinol binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry. 38:2647–2653. 1999. View Article : Google Scholar : PubMed/NCBI
22	Monaco HL, Rizzi M and Coda A: Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein. Science. 268:1039–1041. 1995. View Article : Google Scholar : PubMed/NCBI
23	Chantrel F, Agin A, Offner M, Koehl C, Moulin B and Hannedouche T: Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol. 54:374–381. 2000.PubMed/NCBI
24	Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, et al: Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 51:629–650. 2016. View Article : Google Scholar : PubMed/NCBI
25	European Association for the Study of the Liver, . EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndromeincirrhosis. J Hepatol. 53:397–417. 2010. View Article : Google Scholar : PubMed/NCBI
26	Delanaye P and Mariat C: The applicability of eGFR equations to different opulations. Nat Rev Nephrol. 9:513–522. 2013. View Article : Google Scholar : PubMed/NCBI
27	Ghassemi S and Garcia-Tsao G: Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 21:77–93. 2007. View Article : Google Scholar : PubMed/NCBI
28	Ozdamar SO, Gucer S and Tinaztepe K: Hepatitis-B virus associated nephropathies: A clinicopathological study in 14 children. Pediatr Nephrol. 18:23–28. 2003. View Article : Google Scholar : PubMed/NCBI
29	Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, Durand F, Valla D, Lebrec D and Moreau R: The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study. Liver Int. 30:725–732. 2010. View Article : Google Scholar : PubMed/NCBI
30	Zhou Y, Dong Q, Zhang R, Zhou S, Li L, Cheng K, Kong R, Yu Q, Xu S, Li J, et al: Cerebral hemodynamics and cognitive function in cirrhotic patients with hepatic encephalopathy. Gastroenterol Res Pract. 2016:84850322016. View Article : Google Scholar : PubMed/NCBI
31	Xu L, Dai W, Li J, He L, Wang F, Xia Y, Chen K, Li S, Liu T, Lu J, et al: Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3. Oncotarget. 7:26027–26041. 2016. View Article : Google Scholar : PubMed/NCBI
32	Yang J, Li J, Dai W, Wang F, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Zhu R, et al: Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis. Exp Ther Med. 9:1413–1420. 2015.PubMed/NCBI
33	Liu Z, Wang J, Guo C and Fan X: microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway. Biomed Pharmacother. 69:24–28. 2015. View Article : Google Scholar : PubMed/NCBI